ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
2.000
-0.010 (-0.50%)
At close: Feb 11, 2026, 4:00 PM EST
1.990
-0.010 (-0.50%)
After-hours: Feb 11, 2026, 7:01 PM EST
ProKidney Market Cap
ProKidney has a market cap or net worth of $601.67 million as of February 11, 2026. Its market cap has increased by 184.95% in one year.
Market Cap
601.67M
Enterprise Value
334.18M
1-Year Change
184.95%
Ranking
Category
Stock Price
$2.00
Market Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $50.55M to $601.67M, an increase of 1,090.24%. That is a compound annual growth rate of 70.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 284.51M | -10.27% |
| Dec 31, 2025 | 317.06M | 46.61% |
| Dec 31, 2024 | 216.27M | 80.97% |
| Dec 29, 2023 | 119.50M | -71.69% |
| Dec 30, 2022 | 422.17M | 33.72% |
| Dec 31, 2021 | 315.71M | 524.55% |
| Jun 30, 2021 | 50.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LB Pharmaceuticals | 602.62M |
| MeiraGTx Holdings | 598.05M |
| Design Therapeutics | 585.02M |
| Ginkgo Bioworks Holdings | 574.05M |
| Contineum Therapeutics | 547.94M |
| Vor Biopharma | 546.40M |
| Evommune | 545.68M |
| Keros Therapeutics | 535.29M |